| 109.51 Delayed Data As of Aug 23 |  -2.10 / -1.88%Today’s Change | 103.66 Today|||52-Week Range 132.13 | -5.37% Year-to-Date |
| Previous close | 111.61 |
| Today’s open | 111.46 |
| Day’s range | 108.88 - 112.56 |
| Volume | 3,870,286 |
| Average volume (3 months) | 4,337,201 |
| Market cap | $106.7B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +3.14% |
| Earnings growth (next 5 years) | +9.70% |
| Revenue growth (last year) | +7.36% |
| P/E ratio | 26.0 |
| Price/Sales | 4.87 |
| Price/Book | 11.88 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +0.01 | +0.02% |
| GSKGlaxoSmithKline | +0.21 | +0.51% |
| ABBVAbbVie | -1.55 | -2.30% |
| AZNAstraZeneca | -0.83 | -1.83% |
| Next reporting date | October 23, 2019 |
| EPS forecast (this quarter) | $1.41 |
| Annual revenue (last year) | $24.6B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 13.16% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer David A. Ricks |
Senior VP & President-Manufacturing Operations Myles Oneill |
Corporate headquarters Indianapolis, Indiana |
